Vesicoureteral reflux: Surgical and endoscopic treatment

Research output: Contribution to journalArticle

Abstract

The optimal management of vesicoureteral reflux (VUR) is quite controversial. For many years, only antibiotic prophylaxis and open surgery were considered possible options. Since the first descriptions in the early 1980s, endoscopic treatment (ET) has gained popularity and is now considered a valid alternative both to open surgery and antibiotic prophylaxis. Many surgical antireflux techniques have been described in the past 50 years. The general principle of reflux surgery, usually defined as ureteric reimplantation, is elongation of the submucosal ureteral tunnel with creation of a flap-valve mechanism. The antireflux operation can also be carried out laparoscopically, either extravesically or intravesically (pneumovesicum). Open surgery is associated with a high success rate (>95%) regardless of the technique adopted. However, because it is invasive, it is limited to selected cases. Laparoscopic technique is less invasive, but the mean operative time is much longer and results depend significantly on the learning curve. ET involves injecting material endoscopically into the submucosal space under the ureteric orifice. It is associated with a good success rate (about 80% after one injection). Advantages of this minimally invasive treatment include repeatability and the fact that postoperative complications are rare. With a second injection, after few months if needed, the success rate of ET approaches that of open surgery. Our 20-year experience in ET is described in detail in this paper, as this technique has changed the management algorithm for VUR dramatically.

Original languageEnglish
Pages (from-to)1261-1265
Number of pages5
JournalPediatric Nephrology
Volume22
Issue number9
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Vesico-Ureteral Reflux
Antibiotic Prophylaxis
Therapeutics
Injections
Learning Curve
Replantation
Operative Time

Keywords

  • Endoscopy
  • Laparoscopy
  • Surgery
  • Uropathy
  • Vesicoureteral reflux

ASJC Scopus subject areas

  • Nephrology
  • Pediatrics, Perinatology, and Child Health

Cite this

Vesicoureteral reflux : Surgical and endoscopic treatment. / Capozza, Nicola; Caione, Paolo.

In: Pediatric Nephrology, Vol. 22, No. 9, 09.2007, p. 1261-1265.

Research output: Contribution to journalArticle

@article{0b7e002ab94047dabb88eac8b60ad457,
title = "Vesicoureteral reflux: Surgical and endoscopic treatment",
abstract = "The optimal management of vesicoureteral reflux (VUR) is quite controversial. For many years, only antibiotic prophylaxis and open surgery were considered possible options. Since the first descriptions in the early 1980s, endoscopic treatment (ET) has gained popularity and is now considered a valid alternative both to open surgery and antibiotic prophylaxis. Many surgical antireflux techniques have been described in the past 50 years. The general principle of reflux surgery, usually defined as ureteric reimplantation, is elongation of the submucosal ureteral tunnel with creation of a flap-valve mechanism. The antireflux operation can also be carried out laparoscopically, either extravesically or intravesically (pneumovesicum). Open surgery is associated with a high success rate (>95{\%}) regardless of the technique adopted. However, because it is invasive, it is limited to selected cases. Laparoscopic technique is less invasive, but the mean operative time is much longer and results depend significantly on the learning curve. ET involves injecting material endoscopically into the submucosal space under the ureteric orifice. It is associated with a good success rate (about 80{\%} after one injection). Advantages of this minimally invasive treatment include repeatability and the fact that postoperative complications are rare. With a second injection, after few months if needed, the success rate of ET approaches that of open surgery. Our 20-year experience in ET is described in detail in this paper, as this technique has changed the management algorithm for VUR dramatically.",
keywords = "Endoscopy, Laparoscopy, Surgery, Uropathy, Vesicoureteral reflux",
author = "Nicola Capozza and Paolo Caione",
year = "2007",
month = "9",
doi = "10.1007/s00467-006-0415-9",
language = "English",
volume = "22",
pages = "1261--1265",
journal = "Pediatric Nephrology",
issn = "0931-041X",
publisher = "Springer Verlag",
number = "9",

}

TY - JOUR

T1 - Vesicoureteral reflux

T2 - Surgical and endoscopic treatment

AU - Capozza, Nicola

AU - Caione, Paolo

PY - 2007/9

Y1 - 2007/9

N2 - The optimal management of vesicoureteral reflux (VUR) is quite controversial. For many years, only antibiotic prophylaxis and open surgery were considered possible options. Since the first descriptions in the early 1980s, endoscopic treatment (ET) has gained popularity and is now considered a valid alternative both to open surgery and antibiotic prophylaxis. Many surgical antireflux techniques have been described in the past 50 years. The general principle of reflux surgery, usually defined as ureteric reimplantation, is elongation of the submucosal ureteral tunnel with creation of a flap-valve mechanism. The antireflux operation can also be carried out laparoscopically, either extravesically or intravesically (pneumovesicum). Open surgery is associated with a high success rate (>95%) regardless of the technique adopted. However, because it is invasive, it is limited to selected cases. Laparoscopic technique is less invasive, but the mean operative time is much longer and results depend significantly on the learning curve. ET involves injecting material endoscopically into the submucosal space under the ureteric orifice. It is associated with a good success rate (about 80% after one injection). Advantages of this minimally invasive treatment include repeatability and the fact that postoperative complications are rare. With a second injection, after few months if needed, the success rate of ET approaches that of open surgery. Our 20-year experience in ET is described in detail in this paper, as this technique has changed the management algorithm for VUR dramatically.

AB - The optimal management of vesicoureteral reflux (VUR) is quite controversial. For many years, only antibiotic prophylaxis and open surgery were considered possible options. Since the first descriptions in the early 1980s, endoscopic treatment (ET) has gained popularity and is now considered a valid alternative both to open surgery and antibiotic prophylaxis. Many surgical antireflux techniques have been described in the past 50 years. The general principle of reflux surgery, usually defined as ureteric reimplantation, is elongation of the submucosal ureteral tunnel with creation of a flap-valve mechanism. The antireflux operation can also be carried out laparoscopically, either extravesically or intravesically (pneumovesicum). Open surgery is associated with a high success rate (>95%) regardless of the technique adopted. However, because it is invasive, it is limited to selected cases. Laparoscopic technique is less invasive, but the mean operative time is much longer and results depend significantly on the learning curve. ET involves injecting material endoscopically into the submucosal space under the ureteric orifice. It is associated with a good success rate (about 80% after one injection). Advantages of this minimally invasive treatment include repeatability and the fact that postoperative complications are rare. With a second injection, after few months if needed, the success rate of ET approaches that of open surgery. Our 20-year experience in ET is described in detail in this paper, as this technique has changed the management algorithm for VUR dramatically.

KW - Endoscopy

KW - Laparoscopy

KW - Surgery

KW - Uropathy

KW - Vesicoureteral reflux

UR - http://www.scopus.com/inward/record.url?scp=34247347927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247347927&partnerID=8YFLogxK

U2 - 10.1007/s00467-006-0415-9

DO - 10.1007/s00467-006-0415-9

M3 - Article

C2 - 17277953

AN - SCOPUS:34247347927

VL - 22

SP - 1261

EP - 1265

JO - Pediatric Nephrology

JF - Pediatric Nephrology

SN - 0931-041X

IS - 9

ER -